John Kelly

John Kelly

Operationeel Directeur bij PRECISION BIOSCIENCES, INC.

Vermogen: 879 922 $ op 31-07-2026

59 jaar
Health Technology
Consumer Services
Health Services

Profiel

John Alexander Kelly is currently Director at California Biomedical Innovation Alliance since 2016 and Chief Operating Officer at Precision BioSciences, Inc. starting in 2026.
Former positions include Director-Investor Relations at Pharmacia & Upjohn, Inc., Executive Director-Investor Relations at Novartis Corp.
from 2003 to 2004, Senior Director-Investor Relations at Pharmacia Corp.
from 2002 to 2003, Director at HealthCare Institute of New Jersey, Treasurer & Director at California Life Sciences Association, Vice President-Investor Relations at Bausch & Lomb, Inc. in 2013, Chief Communications Officer & Senior VP-IR at Forest Laboratories, Inc. from 2013 to 2014, Senior Vice President-Investor Relations at Merck & Co., Inc. from 2004 to 2013, Vice President-Investor Relations at Schering-Plough Corp.
USA, Pharmaceutical Sales Representative at The Upjohn Co., Chief Integration Officer & Senior Vice President at Actavis, Inc. from 2014 to 2015, Chief Communications Officer & Executive VP at Allergan UC from 2015 to 2020, and President at Allergan Foundation.
Education includes undergraduate studies at Purdue University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
01-06-2026 125.883 ( 0,52% ) 879 922 $ 31-07-2026

Actieve functies van John Kelly

BedrijvenFunctieBegin
PRECISION BIOSCIENCES, INC. Operationeel Directeur 01-08-2026
Directeur/Bestuurslid 02-08-2016

Eerdere bekende functies van John Kelly

BedrijvenFunctieEinde
ALLERGAN PLC Public Communications Contact 08-05-2020
Corporate Officer/Principal 01-05-2015
FOREST LABORATORIES, INC. Investor Relations Contact 01-07-2014
Investor Relations Contact 01-08-2013
MERCK & CO., INC. Investor Relations Contact 01-05-2013
Ervaring van John Kelly in detail bekijken

Opleiding van John Kelly

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

75

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. John Kelly